Epigenetic histone modifications and master regulators as determinants of context dependent nuclear receptor activity in bone cells

Bone

Volumn 81, Issue , 2015, Pages 757-764

  Pike, J Wesley ^a   Meyer, Mark B ^a   St John, Hillary C ^a   Benkusky, Nancy A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Epigenetics; Genome wide analysis; Osteoblast lineage cells; Transcription

Indexed keywords

CALCITRIOL; CCAAT ENHANCER BINDING PROTEIN BETA; CELL NUCLEUS RECEPTOR; HISTONE; PARATHYROID HORMONE; STEROID HORMONE; TRANSCRIPTION FACTOR RUNX2; VITAMIN D; CALCITRIOL RECEPTOR; CELL RECEPTOR;

ARTICLE; BONE CELL; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; EPIGENETICS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HISTONE ACETYLATION; HISTONE MODIFICATION; HORMONAL REGULATION; HUMAN; NONHUMAN; OSTEOBLAST; PHENOTYPE; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; BONE; CYTOLOGY; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; HISTONE CODE; METABOLISM;

ANIMALS; BONE AND BONES; CALCITRIOL; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; EPIGENESIS, GENETIC; HISTONE CODE; HUMANS; MODELS, BIOLOGICAL; OSTEOBLASTS; PARATHYROID HORMONE; RECEPTORS, CALCITRIOL; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 84955189202     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2015.03.012     Document Type: Review

References (55)

1. Hawkins RD, Hon GC, Ren B. Next-generation genomics: an integrative approach. Nat Rev Genet. Vol 112010:476-486.
2. DunhamI, Kundaje A, Aldred SF, Collins PJ, Davis CA, Doyle F, et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489(7414): 57-74.
3. Ernst J, Kellis M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat Biotechnol 2010;28(8):817-25.
4. HoffmanMM, Ernst J, Wilder SP, Kundaje A, Harris RS, Libbrecht M, et al. Integrative annotation of chromatin elements from ENCODE data. Nucleic Acids Res 2013; 41(2):827-41.
5. Gerstein MB, Kundaje A, HariharanM, Landt SG, Yan KK, Cheng C, et al. Architecture of the human regulatory network derived from ENCODE data. Nature 2012; 489(7414):91-100.
6. Zhou VW, Goren A, Bernstein BE. Charting histone modifications and the functional organization of mammalian genomes. Nat Rev Genet 2011;12(1):7-18.
7. Greer EL, Shi Y. Histone methylation: a dynamic mark in health, disease and inher-itance. Nat Rev Genet 2012;13(5):343-57.
8. Corradin O, Scacheri PC. Enhancer variants: evaluating functions in common disease. Genome Med 2014;6(10):85.
9. Li L, Wei D. Bioinformatics tools for discovery and functional analysis of single nucle-otide polymorphisms. Adv Exp Med Biol 2015;827:287-310.
10. Brookes E, Shi Y. Diverse epigeneticmechanisms of human disease. Annu Rev Genet 2014;48:237-68.
11. Conte M, Altucci L. Molecular pathways: the complexity of the epigenome in cancer and recent clinical advances. Clin Cancer Res 2012;18(20):5526-34.
12. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011; 473(7345):43-9.
13. Yun M, Wu J, Workman JL, Li B. Readers of histone modifications. Cell Res 2011; 21(4):564-78.
14. Linghu C, Zheng H, Zhang L, Zhang J. Discovering common combinatorial histone modification patterns in the human genome. Gene 2013;518(1):171-8.
15. Meyer MB, Benkusky NA, Pike JW. The RUNX2 cistrome in osteoblasts: characteriza-tion, down-regulation following differentiation, and relationship to gene expression. J Biol Chem 2014;289(23):16016-31.
16. Wu H, Whitfield TW, Gordon JA, Dobson JR, Tai PW, van Wijnen AJ, et al. Genomic occupancy of Runx2 with global expression profiling identifies a novel dimension to control of osteoblastogenesis. Genome Biol 2014;15(3):R52.
17. St John HC, Bishop KA, Meyer MB, Benkusky NA, Leng N, Kendziorski C, et al. The os-teoblast to osteocyte transition: epigenetic changes and response to the vitamin d3 hormone. Mol Endocrinol 2014;28(7):1150-65.
18. Bishop KA, Coy HM, Nerenz RD, Meyer MB, Pike JW. Mouse Rankl expression is reg-ulated in T cells by c-Fos through a cluster of distal regulatory enhancers designated the T cell control region. J Biol Chem 2011;286(23):20880-91.
19. Ho L, Crabtree GR. Chromatin remodelling during development. Nature 2010; 463(7280):474-84.
20. Vigano MA, Ivanek R, Balwierz P, Berninger P, van Nimwegen E, Karjalainen K, et al. An epigenetic profile of early T-cell development from multipotent progenitors to committed T-cell descendants. Eur J Immunol 2014;44(4):1181-93.
21. Zhang JA, Mortazavi A, Williams BA, Wold BJ, Rothenberg EV. Dynamic transforma-tions of genome-wide epigeneticmarking and transcriptional control establish T cell identity. Cell 2012;149(2):467-82.
22. Lin YC, Jhunjhunwala S, Benner C, Heinz S, Welinder E, Mansson R, et al. A globalnetwork of transcription factors, involving E2A, EBF1 and Foxo1, that orchestratesB cell fate. Nat Immunol 2010;11(7):635-43.
23. Kaikkonen MU, Spann NJ, Heinz S, Romanoski CE, Allison KA, Stender JD, et al. Re-modeling of the enhancer landscape duringmacrophage activation is coupled to en-hancer transcription. Mol Cell 2013;51(3):310-25.
24. Stender JD, Pascual G, LiuW, Kaikkonen MU, Do K, Spann NJ, et al. Control of proin-flammatory gene programs by regulated trimethylation and demethylation of his-tone H4K20. Mol Cell 2012;48(1):28-38.
25. Zhang DX, Glass CK. Towards an understanding of cell-specific functions of signal-dependent transcription factors. J Mol Endocrinol 2013;51(3):T37-50.
26. Long F. Building strong bones: molecular regulation of the osteoblast lineage. NatRev Mol Cell Biol 2012;13(1):27-38.
27. Karsenty G. Transcriptional control of skeletogenesis. Annu Rev Genomics HumGenet 2008;9:183-96.
28. Stein GS, Stein JL, vanWijnen AJ, Lian JB, Zaidi SK, Nickerson JA, et al. An archi-tectural genetic and epigenetic perspective. Integr Biol (Camb) 2011;3(4):297-303.
29. Dudakovic A, Evans JM, Li Y, Middha S, McGee-Lawrence ME, van Wijnen AJ, et al. Histone deacetylase inhibition promotes osteoblast maturation by altering the his-tone H4 epigenome and reduces Akt phosphorylation. J Biol Chem 2013;288(40):28783-91.
30. Westendorf JJ. Histone deacetylases in control of skeletogenesis. J Cell Biochem2007;102(2):332-40.
31. Meyer MB, Goetsch PD, Pike JW. Genome-wide analysis of the VDR/RXR cistrome inosteoblast cells provides new mechanistic insight into the actions of the vitamin Dhormone. J Steroid Biochem Mol Biol 2010;121(1-2):136-41.
32. Meyer MB, Goetsch PD, Pike JW. VDR/RXR and TCF4/β-catenin cistromes in coloniccells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression. MolEndocrinol 2012;26(1):37-51.
33. Heikkinen S, Väisänen S, Pehkonen P, Seuter S, Benes V, Carlberg C. Nuclear hormone1α, 25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDRchromatin occupancy. Nucleic Acids Res 2011.
34. Ramagopalan S, Heger A, Berlanga A, Maugeri N, Lincoln M, Burrell A, et al. A ChIP-seq defined genome-widemap of vitamin D receptor binding: associationswith dis-ease and evolution. Genome Res 2010.
35. MeyerMB, Benkusky NA, Lee CH, Pike JW. Genomic determinants of gene regulationby 1, 25-dihydroxyvitamin D3 during osteoblast-lineage cell differentiation. J BiolChem 2014;289(28):19539-54.
36. Ding N, Yu RT, Subramaniam N, ShermanMH, Wilson C, Rao R, et al. A vitamin D re-ceptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 2013;153(3):601-13.
37. Kim S, Shevde N, Pike J. 1, 25-Dihydroxyvitamin D3 stimulates cyclic vitamin D re-ceptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acet-ylation in intact osteoblasts. J Bone Miner Res 2005;20(2):305-17.
38. Zella LA, Kim S, Shevde NK, Pike JW. Enhancers located within two introns of the vita-min D receptor genemediate transcriptional autoregulation by 1, 25-dihydroxyvitaminD3. Mol Endocrinol 2006;20(6):1231-47.
39. KimS, YamazakiM, Zella LA, Shevde NK, Pike JW. Activation of receptor activator of NF-kappaB ligand gene expression by 1, 25-dihydroxyvitamin D3 ismediated throughmul-tiple long-range enhancers. Mol Cell Biol 2006;26(17):6469-86.
40. Sutton AL, MacDonald PN. Vitamin D: more than a "bone-a-fide" hormone. MolEndocrinol 2003;17(5):777-91.
41. Shahbazian MD, Grunstein M. Functions of site-specific histone acetylation anddeacetylation. Annu Rev Biochem 2007;76:75-100.
42. Berger SL. The complex language of chromatin regulation during transcription. Nature 2007;447(7143):407-12.
43. Pan YF, Wansa KD, Liu MH, Zhao B, Hong SZ, Tan PY, et al. Regulation of estrogenreceptor-mediated long range transcription via evolutionarily conserved distal re-sponse elements. J Biol Chem 2008;283(47):32977-88.
44. Meyer MB, Goetsch PD, Pike JW. A downstream intergenic cluster of regulatory en-hancers contributes to the induction of CYP24A1 expression by 1alpha, 25-dihydroxyvitamin D3. J Biol Chem 2010;285(20):15599-610.
45. Ruthenburg AJ, Allis CD, Wysocka J. Methylation of lysine 4 on histone H3: intricacyof writing and reading a single epigenetic mark. Mol Cell 2007;25(1):15-30.
46. Calo E, Wysocka J. Modification of enhancer chromatin: what, how, and why? MolCell 2013;49(5):825-37.
47. Gordon JA, MontecinoMA, Aqeilan RI, Stein JL, Stein GS, Lian JB. Epigenetic pathwaysregulating bone homeostasis: potential targeting for intervention of skeletal disor-ders. Curr Osteoporos Rep 2014;12(4):496-506.
48. Hirata M, Kugimiya F, Fukai A, Ohba S, Kawamura N, Ogasawara T, et al. C/EBPbetaPromotes transition from proliferation to hypertrophic differentiation ofchondrocytes through transactivation of p57. PLoS One 2009;4(2):e4543.
49. Tominaga H, Maeda S, Hayashi M, Takeda S, Akira S, Komiya S, et al. CCAAT/enhancer-binding protein beta promotes osteoblast differentiation by enhancingRunx2 activity with ATF4. Mol Biol Cell 2008;19(12):5373-86.
50. Bikle DD. Vitamin D, and bone. Curr Osteoporos Rep 2012;10(2):151-9.
51. Eisman JA, Bouillon R. Vitamin D: direct effects of vitamin D metabolites on bone:lessons from genetically modified mice. Bonekey Rep 2014;3:499.
52. Lieben L, Masuyama R, Torrekens S, Van Looveren R, Schrooten J, Baatsen P, et al. Normocalcemia ismaintained inmice under conditions of calciummalabsorption by vi-tamin D-induced inhibition of bonemineralization. J Clin Invest 2012;122(5):1803-15.
53. Leibbrandt A, Penninger JM. RANK/RANKL: regulators of immune responses andbone physiology. Ann N Y Acad Sci 2008;1143:123-50.
54. St John HC, MeyerMB, Benkusky NA, Carlson AH, PrideauxM, Bonewald LF, et al. Theparathyroid hormone-regulated transcriptome in osteocytes: Parallel actions with1, 25-dihydroxyvitamin D3 to oppose gene expression changes during differentia-tion and to promote mature cell function. Bone 2014;72C:81-91.
55. Bellido T, Saini V, Pajevic PD. Effects of PTH on osteocyte function. Bone 2013;54(2):250-7.